baber/WOPTO huggingface dataset:
Patent MX-160181-A (MX)
Inventor: BOYS JOHN TALBOT
IPC: G01D1/00
Filed: 1975-09-17
Abstract: A meter for determining stiffness or torque gradient including, in one embodiment, a deflectable coupling connected between an output shaft and a power input shaft, sensing means for developing two separate series of signals representative of the displacement of the input and output shafts respectively, a comparator for determining from the two series of signals a function of the stiffness or torque gradient and, in another embodiment, including a single shaft having an input end and an output end, transducer means associated with the shaft for developing a signal representative of the torque being applied through the shaft, sensing means for developing a signal representative of the displacement of the shaft, and comparator means for determining from the two signals a function of the stiffness or torque gradient. Either embodiment of the stiffness meter may be used for tightening a fastener by including an additional circuit responsive to the comparator output for sequentially storing information representative of the maximum stiffness developed up to any given point during the tightening operation and for producing a stop signal when the instantaneous stiffness has dropped to a predetermined ratio of the maximum stiffness.
Patent MX-157433-A (MX)
Inventor: WEITZNER JORGE MANDOKI
IPC: C07C29/09
Filed: 1981-06-12
Abstract: Page 1 CONTINUOUS PROCEDURE FOR OBTAINING PURE TEREPHTHALIC ACID AND GLYCOL STARTING FROM POLYETHYLENE TEREPHTHALATE WASTE of the invention A procedure is described to obtain pure terephthalic acid and glycol, which consists in carrying out, in a continuous manner and in the presence of decolorizing carbon, an aqueous and neutral hydrolysis of polyethylene terephthalate waste, under high temperature and pressure conditions, continuously filtering the product at the hydrolysis temperature and crystallizing the terephthalic acid, while the mother liquors are subjected to distillation in order to obtain the glycol. Basis of the invention Field of the invention The invention under consideration is related to a continuous method which permits-obtaining pure terephthalic acid and glycol and more specifically, it is related with a procedure which utilizes as a raw material polyethylene terephthalate waste and in which it is not necessary to first separate the crude or impure terephthalic acid in order to purify it in a subsequent stage by means of one
Patent MX-162685-A (MX)
Inventor: DENNIS ALAN JAMES
IPC: C07C45/82
Filed: 1983-06-10
Abstract: A continuous process for the production an aldehyde by hydroformylation of an optionally substituted alpha-olefin comprises:providing a hydroformylation zone containing a charge of a liquid reaction medium having dissolved therein a complex rhodium hydroformylation catalyst comprising rhodium in complex combination with carbon monoxide and with a cyclic phosphite having a bridgehead phosphorus atom linked to three oxygen atoms at least two of which form together with the bridgehead phosphorus atom part of a ring;supplying said alpha-olefin to the hydroformylation zone;maintaining temperature and pressure conditions in the hydroformylation zone conducive to hydroformylation of the alpha-olefin;supplying make-up hydrogen and carbon monoxide to the hydroformylation zone; andrecovering from the liquid hydroformylation medium a hydroformylation product comprising at least one aldehyde.
Patent MX-156676-A (MX)
Inventor: KAWAKAMI KENJI
IPC: G11B23/087
Filed: 1984-09-19
Abstract: A magnetic tape cassette for use in a magnetic recording/reproducing apparatus has a sliding plate (10) provided on a lower surface (3b) to selectively cover and expose insertion apertures (5,6) that open into the interior of the cassette. A front lid (9) is provided which may be pivoted to either expose or cover a front opening (1a) in the cassette through which tape (7) may be withdrawn for a recording/ reproducing operation. When the front lid (9) is in its closed position and the sliding plate (10) covers the insertion apertures (5, 6), the front lid (9) is locked in its closed position. The magnetic tape cassette is thereby closed to prevent dust, oil and other contaminants from damaging the magnetic tape (7) within.
Patent NZ-223045-A (NZ)
Title: Fluticasone propionate compositions with an enteric coating
Inventor: RICHARDS D A
IPC: A61K31/56
Filed: 1987-12-22
Abstract: Use of fluticasone propionate in the treatment of bowel diseases when administered by the oral, stomal or rectal routes.
Patent NZ-223897-A (NZ)
Title: Optical displacement sensor using colour variations to monitor displacement of two gratings
Inventor: JONES G R
IPC: G01B11/00
Filed: 1988-03-15
Abstract: A moire fringe displacement sensor includes first and second gratings (3) (4), a polychromatic light source (1) illuminating the gratings, and a detector (8). The gratings are disposed such that a relative displacement of the first and second gratings causes a variation in the colour of the light reaching the detector. The detector (8) comprises first and second photo-responsive elements (11) (12), the responsivity with respect to wavelength of the first element (11) being different from that of the second (12). Signals from the photo-responsive elements are fed to a micro-processor (15) which calculates the colour of the light incident on the detector as represented by two or more parameters on the Chromaticity (CIE) Diagram, and interprets the colour in terms of the displacement of the first and second gratings.
Patent NZ-225077-A (NZ)
Title: Transcription based nucleic acid amplification/detection systems, having use in the detection of specific sequences on an hiv virus
Inventor: GINGERAS THOMAS RAYMOND
IPC: C12Q1/68
Filed: 1988-06-17
Abstract: A method of amplifying a target sequence in a sample containing nucleic acid is provided which comprises hybridizing to the target sequence a first nucleic acid primer including a promoter sequence, extending the primer in a polymerase extension reaction complementarily to the target sequence to form a duplex, rendering the duplex single stranded, hybridizing to the extension product containing the promoter a second primer and carrying out a second extension reaction, and employing the second duplex as a template for the production of a plurality of RNA transcripts, the method being characterised in that the first and/or second primer includes a sequence necessary to allow the RNA product to be replicated by replicase induction and in that the RNA transcripts are so replicated.
Patent NZ-229100-A (NZ)
Title: Cross-linked carboxy acidic polysaccharides comprising at least partially cross-linked hyaluronic acid; use as drug carriers, in the manufacture of surgical articles and industry
Inventor: DELLA VALLE FRANCESCO
IPC: A61L31/04
Filed: 1989-05-12
Abstract: Inter and/or intramolecular cross-linked esters of acid polysaccharides are disclosed in which a part or all of the carboxy groups are esterified with hydroxyl groups of the same molecule and/or of different molecules of the acid polysaccharide. These inner cross-linked esters of polysaccharide acids are useful in the field of biodegradable plastic materials, to manufacture sanitary and surgical articles, in the cosmetic and pharmaceutical fields, in the food industry and in many other industrial fields.
Patent NZ-229707-A (NZ)
Title: Tablet formulation containing a pesticide, and which breaks down in water to a fine dispersion
Inventor: MOORE EARL PHILLIP
IPC: A01N25/30
Filed: 1989-06-26
Abstract: A tablet formulation comprising (i) a pesticide characterized by low or no water solubility, and (ii) a complementary delivery system containing an organic acid, an inorganic base, a dispersant, a disintegrant, and a wetting agent.
Patent NZ-238208-A (NZ)
Title: Polypeptides with amino acid sequence substantially that of human fibronectin fibrin binding domain, their preparation and compositions and imaging agents containing them
Inventor: VOGEL TIKVA
IPC: A61K47/48
Filed: 1991-05-21
Abstract: This invention provides an imaging agent which comprises a polypeptide labeled with an imageable marker, such polypeptide having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin. The invention further provides a method wherein the imaging agent is used for imaging a fibrin-containing substance, i.e., a thrombus or atherosclerotic plaque. Further provided are plasmids for expression of polypeptides having an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and being capable of binding to fibrin, hosts containing these plasmids, methods of producing the polypeptides, methods of treatment using the polypeptides, and methods of recovering, refolding and reoxidizing the polypeptides. The invention also provides for purified polypeptides substantially free of other substances of human origin which have an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and which are capable of binding to fibrin.
Patent NZ-238487-A (NZ)
Title: An additive for masonry cement comprising a water-repelling agent, a synthetic latex, an alkanolamine, and a set-retarding agent
Inventor: CHIN DAVID
IPC: C04B24/00
Filed: 1991-06-11
Abstract: The present invention relates to an additive for mortars which provides a mortar having good water repellency, excellent adhesion to difficult substrates, e.g. water repellant masonry bricks and blocks, and superior compressive strength. More particularly, the present invention relates to such an additive which comprises a water repelling agent, a synthetic latex, an alkanolamine, and a set retarding agent.
Patent NZ-239188-A (NZ)
Title: Modification of concrete properties by introduction of solid admixture in a non water-soluble paper container
Inventor: VALLE STEPHEN ARMANDO
IPC: B28C7/06
Filed: 1991-07-30
Abstract: The present invention relates to a method for modifying the properties of a concrete by introducing a solid admixture, contained in a paper package, into a fresh concrete, said solid admixture being selected from the group consisting of air-entraining admixtures, air detrainer admixture, accelerating admixture, alkali-reactivity redurer, superplasticizer, pumping aids, water-reducing admixture, corrosion inhibitor, permeability reducer, fibers, and mixtures thereof; and mixing the fresh concrete in a batch type mixer for sufficient time to cause the packaging material to disintegrate and distribute the admixture relatively uniformly throughout the fresh concrete.
Patent NZ-239233-A (NZ)
Title: Gonadotrophin-releasing hormone antagonist peptides
Inventor: KONIG WOLFGANG
IPC: C07K7/23
Filed: 1991-08-02
Abstract: Peptides of the formula <IMAGE> in which X is alkanoyl, A is optionally substituted D-Na(2), D-Phe or D-Trp, B is optionally substituted D-Phe, C is D-Pal(3) or optionally substituted D-Phe or D-Trp, and D is Tyr or His, E is D-Ser(R<1>), F is Leu, Trp or Phe, G is L-Ser(R<1>), H is Gly-NH2, D-Ala-NH2 or azagly-NH2 and R<1> is a glycosyl radical, have inhibitory effects on the formation of the gonadotropins lutropin and follitropin and thus also on the synthesis of testosterone and oestrogen. A process for the preparation of these peptides is described.
Patent NZ-246576-A (NZ)
Title: Composite membrane comprising a reinforcing mesh formed from hyaluronic acid and/or alginic acid embedded in a matrix comprising hyaluronic acid, alginic acid and/or a gelled polysaccharide
Inventor: DORIGATTI FRANCO
IPC: D04H1/42
Filed: 1992-12-18
Abstract: Biomaterials are disclosed comprised of biodegradable, biocompatible, and bioabsorbable composite membranes for use in surgery for the guided regeneration of tissues. The composite membranes are comprised of threads embedded in a matrix, wherein both the matrix and the threads can be comprised of esters of hyaluronic acid, used singly or in combination, or esters of hyaluronic acid in combination with esters of alginic acid or other polymers.
Patent NZ-250582-A (NZ)
Title: Phenylsulphonylmethylsulphonyl derivatives; parasiticidal formulations and methods of use
Inventor: WICKISER DAVID IRA
IPC: A61K31/425
Filed: 1993-12-23
Abstract: The present invention is directed to the use of disulfonyl methane compounds for the control of parasites in vertebrate animals.
Patent NZ-253947-A (NZ)
Title: Sanitary napkin with flaps and recessed areas therefor
Inventor: OSBORN THOMAS WARD
IPC: A61F/
Filed: 1993-06-23
Abstract: An absorbent article such as a sanitary napkin, having flaps and a recessed area wherein the flaps may be tucked.
Patent NZ-260195-A (NZ)
Title: Additive for cement compositions comprising a polymer formed from maleic anhydride and at least two different vinyl poly(oxyalkylene) ethers; cement compositions
Inventor: HONDA SUSUMU
IPC: C08F290/06
Filed: 1994-03-28
Abstract: A cement admixture which when added to a cement composition, such as cement mortar or concrete inhibits slump-loss of the cement composition and improve its workability and applicability. The admixture is composed of copolymers from an alkenyl ether, a polyalkenyl ether and maleic anhydride.
Patent NZ-265091-A (NZ)
Title: Dna constructs for inserting heterologous gene sequences into a host genome
Inventor: SMITH AUSTIN GERARD
IPC: C07K14/81
Filed: 1994-04-21
Abstract: DNA construct for inserting a heterologous gene (HG) into a host genome is of formula 5'-X-A-P-B-Q-C-Y-3' (I). X and Y are sequences homologous with parts of the host genome; P = internal ribosome entry side (IRES); Q = HG; A, B, C are optional linkers. Also new are (1) cells, animals and their descendants contg. HG inserted using (I) and (2) vectors contg. (I).
Patent NZ-274509-A (NZ)
Title: Alpha-1,4-glucan lyase and its preparation from a fungally infected algae
Inventor: YU SHUKUN
IPC: C12N9/00
Filed: 1994-10-15
Abstract: PCT No. PCT/EP94/03399 Sec. 371 Date Jul. 2, 1996 Sec. 102(e) Date Jul. 2, 1996 PCT Filed Oct. 15, 1994 PCT Pub. No. WO95/10618 PCT Pub. Date Apr. 20, 1996A method of preparing  alpha -1,4-glucan lyase enzymes is described. The method comprises isolating the enzymes from a fungally infected algae. The amino acid sequences of the enzymes have been determined. The nucleic acid sequences coding for the enzymes have also been determined.
Patent NZ-309563-A (NZ)
Title: Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
Inventor: BRIGGS STEVEN P
IPC: C12N15/01
Filed: 1996-06-05
Abstract: A methodology for ascertaining gene function entails selection of mutations in androgenetic haploids which are produced by fertilizing a maize plant carrying the indeterminate gametophyte gene (ig) with pollen obtained from a mutagenized plant. Genes that control quantitative characters can be identified, for example, by fertilizing a first inbred carrying the ig gene with pollen from a second inbred that has been mutagenized. Changes in the phenotype of the hybrid progeny then are identified and characterized. A method for direct selection of androgenetic haploids is provided.
Patent NZ-324630-A (NZ)
Title: Apparatus to be mounted on a container comprising a spout structure and a retention pocket containing a beneficial agent
Inventor: MAZER TERRENCE B
IPC: A47G21/18
Filed: 1996-12-12
Abstract: Apparatus for adding a beneficial agent to a liquid for drinking during oral administration includes a support structure extending transversely across an imperforate walled zone such as the upper end or neck of a bottle or vessel, or of a funnel-like adapter attached to the top of the vessel, with a retention pocket with liquid penetrable walls held by the support structure and comprising at least one beneficial agent secured therein whereby the beneficial agent is taken up in the liquid for drinking during or just prior to oral administration. The beneficial agent may be in either or both of controlled release dosage form or non-controlled release dosage form and may be one or more of nutrients, medicaments, probiotics, electrolytes, rehydration solutions and diagnostic agents, to which a flavoring agent may be added. In the novel method a support structure with a retention pocket comprising at least one beneficial agent is provided in a bottle or vessel with the support structure extending transversely of the neck or top of the bottle or vessel or a drinking tube extending thereinto. The bottle or vessel is provided with a liquid for drinking selected from a liquid nutritional product, a beverage or water and the liquid is contacted with the beneficial agent during or just before oral administration thereof.
Patent NZ-330266-A (NZ)
Title: Regular division of melt flow in extrusion of blown films in an extrusion die having multiple stacked die layers in the direction parallel to the central axis
Inventor: CREE ROBERT E
IPC: B29C48/10
Filed: 1997-08-26
Abstract: An extrusion die is disclosed having a plurality of die layers stacked one upon the other in a direction generally parallel to the central axis. Each of the layers has an annular flow distribution ring (40) having an outer generally cylindrical surface and an annular feed ring surrounding and engaging the outer surface of the distribution ring (42, 42d). At the engaged surfaces of the feed and distribution ring, the flow from the feed ring is divided into a number of substantially equal flow portions. Seals (43a, 43b) between adjacent engaged surfaces confine the flow between the circumferential surfaces of the feed and distribution ring. Half of the flow portions are directed to a recombination region (45, 46) on one side of the distribution ring (42d), and half are directed to a recombination region (45, 46) on the other side of the ring (42d). In recombining, weld lines are formed in high flow areas minimizing the deleterious effect of polymer degradation. Subsequently, the flows on the opposite sides of the distribution ring (42d) are recombined such that the weld lines from one half are first modified to exhibit lower flow and then are layered with non-weld line portions modified to exhibit higher flow from the other half. This further minimizes the negative effect of weld line areas. Flow from the two sides is regularly divided to yield even distribution of the combined flows.
Patent NZ-332493-A (NZ)
Title: An impeller and fan incorporating same, with impeller having inwardly curved airfoil type blades located spaced about axis
Inventor: ROLLO PETER ERIC
IPC: F04D29/18
Filed: 1997-05-07
Abstract: An impeller (10) is disclosed having an axis about which the impeller is rotatable in a working direction of rotation A. A plurality of aerofoil blades (14) are spaced from and arranged about the axis. The inwardly axis-facing surface (16) of each blade (14) defines a longer fluid flow path across the blade than the opposite outwardly-facing surface (18). Each blade has an angle of attack from 0° up to a positive angle of attack less than that at which the blade will induce turbulent fluid flow when the impeller is rotated in a fluid at a working speed in the working direction of rotation A. During such rotation the impeller induces an inlet fluid flow generally axially toward the impeller and an outward fluid flow away from the impeller in directions generally inclined about 30° or more or less relative to axis.
Patent NZ-332751-A (NZ)
Title: A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
Inventor: ADAMSON LARS
IPC: A61K38/43
Filed: 1997-05-13
Abstract: A process for reducing the detrimental influence of certain proteases on recombinant human protein and polypeptide molecules in a cell culture medium by: 1. adding an inhibitor of metal-dependent proteases; or 2. chymotrypsins to the cell culture medium. The process also relates to a cell culture medium for cultivating cells expressing and secreting a biologically active recombinant human polypeptide containing an inhibitor of metal-dependent proteases or chymotrypsins, or a combination thereof. The use of recombinant factor VIII which has been produced in a cell culture medium according to the present process for the manufacture of a medicament for administration to a patient having the symptoms of Hemophilia A is also described.
Patent NZ-333497-A (NZ)
Title: High dose liposomal aerosol formulations comprising cyclosporin A or budesonide
Inventor: WALDREP J CLIFFORD
IPC: A61K9/12
Filed: 1997-07-02
Abstract: The specification describes a high dose pharmaceutical liposome aerosol composition comprising: a) 12-30mg/ml of cyclosporin A or budesonide and b) 130-375 mg/ml of a phospholipid starting reservoir composition. The aerosols are used to treat immunologically mediated lung disease
Patent NZ-336531-A (NZ)
Title: Method for the manufacture of a laser-precut pack
Inventor: OLIVIERI ALAIN
IPC: B29C59/00
Filed: 1997-12-31
Abstract: Disclosed is a method for the manufacture of a pack, particularly intended for undergoing preservation treatment, from at least one film (10) comprising two plastic layers, an upper (11) and a lower (12), which form the outer and inner faces of said pack, and a light-metal central layer (13) sandwiched between said upper and lower layers.  Prior to the operations to make the pack, a laser beam is applied solely to the lower layer of said film, said lower layer forming the inner face of said pack, in order to produce, virtually in the entire thickness of said lower layer, at least one perforation (14) forming at least one precut line.
Patent NZ-501602-A (NZ)
Title: A method for projection mammography characterised by the contrast media used (iodine or bromine), further containing other intravenous contrast media agents such as metal chelators
Inventor: SPECK ULRICH
IPC: A61K49/04
Filed: 1998-06-19
Abstract: The use of intravenous contrast agents for projection mammography and devices for carrying out projection mammography. The method relates to the use of intravenous contrast agents for producing a diagnostic medium for projection mammography. With the additional intravenous administration of contrast agent, projection mammography attains a sensitivity comparable to the most modern methods, such as magnetic resonance tomography (MRT) while having a wider range of applications and avoiding the cost of MRT. This method is simple and can be carried out without special inconvenience for the patients. It (a) considerably increases the sensitivity for demonstrating focal lesions in the mammae and (b) provides additional information on the character of previously detected lesions.
Patent NZ-502125-A (NZ)
Title: Enantiomers of 4-[[(cyanoimino)-[(1,2,2-trimethylpropyl) amino]methyl]amino] benzonitrile and their use in the treatment of hair loss
Inventor: ATWAL KARNAIL S
IPC: A61Q7/00
Filed: 1998-08-03
Abstract: The (R)-enantiomer of 4-[[(cyanoimino)-[(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile (formula 1), and pharmaceutically acceptable salts.  The compound is useful for promoting hair growth such as in male pattern baldness.